CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast CancerMatthew J. Meyer(Bristol-Myers Squibb (Germany)), Barbara K. Vonderhaar(National Cancer Institute)Cancer ResearchMay 18, 201010.1158/0008-5472.can-09-3619Cited by 180SaveCiteExport RISWatch citationsRelated PapersAllosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases|Nature|2016|925Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer|BMC Cancer|2012|48